# Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus

> **NCT01449747** · PHASE4 · COMPLETED · sponsor: **The Catholic University of Korea** · enrollment: 24 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Sitagliptin

## Key facts

- **NCT ID:** NCT01449747
- **Lead sponsor:** The Catholic University of Korea
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2014-08
- **Final completion:** 2015-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-12-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01449747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01449747, "Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01449747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*